The classic website will no longer be available as of June 25, 2024. Please use the modernized ClinicalTrials.gov.
Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT04209205
Brief Title: Study to Demonstrate the Efficacy, Safety and Tolerability of Intravenous Secukinumab up to 52 Weeks in Subjects With Active Psoriatic Arthritis (INVIGORATE 2)

First Submitted : October 30, 2019
First Submitted that Met QC Criteria : December 19, 2019
First Posted : December 24, 2019

Results First Submitted : May 8, 2023
Results First Posted with QC Comments : June 6, 2023
Results First Submitted that Met QC Criteria : April 23, 2024
Results First Posted : April 26, 2024

Certification/Extension First Submitted : October 4, 2022
Certification/Extension First Posted : April 26, 2024

Last Update Submitted that Met QC Criteria : April 23, 2024
Last Update Posted : April 26, 2024